Bacterin Reports Further Expansion of Sales Force

Loading...
Loading...
Bacterin International Holdings, Inc.
BONE
, a leader in the development of bone graft material and bioactive coatings for medical applications, today announced three senior additions to its Field Sales Organization. Amy Radtke has joined us as a Director of IDN/ National Accounts. Amy has 14 years of medical sales and national management experience with a track record of success at Lumenis, Burwood Group, Inc., and Dräger Medical, Inc. Troy Knief has also joined us as a Director of IDN/National Accounts. In his 13 years of medical sales, sales management and national account management experience he brings a track record of success at Baxter Healthcare/ApaTech Division, Anulex Technologies, Synthes Spine, MedPointe Pharmaceuticals and Forest Pharmaceuticals. Kevin M. O'Dare has joined us as Regional Vice President in our Pennsylvania and New England region. With over 14 years in the medical device field, he brings a track record of success at Olympus Biotech (formerly Stryker Biotech), Ethicon-EndoSurgery and Osteotech, Inc. Robert Di Silvio, President explained, "We see an excellent opportunity for growth in Integrated Delivery Networks (IDNs), and the Federal Government, where the organizations can define and dictate product usage and can effectively influence the end-user surgeon. For this reason, one leg of Bacterin's strategy is to add experienced selling resources with relationships in GPO/IDN and Federal Government immediately."
Loading...
Loading...
Posted In: NewsPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...